Cargando…
Reducing tobacco-associated lung cancer risk: a study protocol for a randomized clinical trial of AB-free kava
BACKGROUND: Tobacco use is the leading cause of many preventable diseases, resulting in premature death or disease. Given that the majority of adult who smoke want to stop, this health burden could be significantly reduced if the success rate of tobacco cessation can be improved. In addition, most a...
Autores principales: | Xing, Chengguo, Malaty, John, Malham, Melissa Bou, Nehme, Anna Maria Abi, Freeman, Breanne, Huo, Zhiguang, Firpi-Morrel, Roberto, Salloum, Ramzi G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847434/ https://www.ncbi.nlm.nih.gov/pubmed/36653872 http://dx.doi.org/10.1186/s13063-023-07081-x |
Ejemplares similares
-
Opportunities and Challenges of Kava in Lung Cancer Prevention
por: Freeman, Breanne, et al.
Publicado: (2023) -
Kava as a Clinical Nutrient: Promises and Challenges
por: Bian, Tengfei, et al.
Publicado: (2020) -
Kava-Kava in Gonorrhœa
Publicado: (1893) -
Kava, Kawa, Kava-Kava—A Powerful Anæsthetic and Spinal Depressant
Publicado: (1886) -
Kava for the treatment of generalised anxiety disorder (K-GAD): study protocol for a randomised controlled trial
por: Savage, Karen M., et al.
Publicado: (2015)